AESKU.GROUP Completes Acquisition of MBL Bion
AESKU.GROUP finalized acquisition of immunofluorescence assay specialist MBL Bion, expanding IFA product menu and production operations.
Tuesday April 10th, 2018, was the official start date for the HELIOS system at the Vicente Corral Moscoso Regional Hospital in the city of Cuenca, Ecuador.
This public-sector hospital has been named ‘number one in service’ in its region.
Its clinical lab performs high-complexity routine, emergency and outpatient testing 24 hours a day, 7 days a week while serving as a reference location for a network of six area labs and the Teofilo Davila de Machala, Isidro Ayora de Loja, and Jose Carrasco Arteaga of the IESS – Cuenca Hospitals. Read more...
Best Review Paper Award goes to…
Prof. Aaron Lerner, Dr. Sandra Neidhöfer and Dr. Torsten Matthias received the Best Review Paper Award 2018 from the journal Microorganism with “The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists Microorganisms”. Read more...
ICAP Compliant IFA QC now available from AESKU
AESKU is introducing a new Immunofluorescence Assay (IFA) Quality Control product line – AESQC IFA – that complies with International Consensus on Antinuclear Antibody Patterns (ICAP) nomenclature.
QCs in IFA are not only important as part of assay quality management, but now as IFA readers are becoming standard devices in laboratories, assuring their ability to read patterns in a standardized manner has also become important.
The AESQC IFA product line allows laboratories to compare IFA reader performance to a set of controls validated and standardized to the ICAP nomenclature. Read more...
Complete IFA Automation with HELIOS is a ‘Dream Come True’ for SSM Health
Wesley Badley, Clinical Laboratory Supervisor at St. Anthony’s Hospital in Oklahoma City, Oklahoma, had an IFA problem. His lab performs ANA testing for the hospital, off-site SSM facilities and affiliated rheumatologists.
“The main reason we were looking at the HELIOS was our sheer volume,” said Badley. “We couldn’t afford in our facility to sit around and have one full FTE be dedicated to doing manual IFA, ANA; it just wasn’t feasible. Also, just finding qualified technicians is a very hard thing to do in our area. Having people there that can read ANAs and read those patterns was hard.” Read more...
AESQC.com Web Portal, a Quality Control Resource, now Available from AESKU
AESKU announces the launch of AESQC.com, an online Quality Control resource providing lot-specific information, including pattern images, to help laboratories improve their Immunofluorescence Assay quality. Read more...
2nd Latin American Workshop, 2018
From 24th to 27th of September 2018, AESKU organized the second Latin America workshop in Cancun (Mexico).
We were delighted with the overall response and welcomed 26 participants from Colombia, Panama, Cuba, Costa Rica, Ecuador, Mexico, Peru, Bolivia, El Salvador, Paraguay, Spain and Brazil.
Since 2014, the Stifterverband acknowledges research companies that embrace their special responsibility for state and society with the "Innovative through Research" seal. Now Aesku.Diagnostics has received the award for its research competence and innovative abilities. Read more...
ICAP Compatible IFA Quality Controls Now Available from AESKU
AESKU announces a new ICAP compatible Immunofluorescence Assay (IFA) Quality Control (QC) product line and supporting Quality Assurance tool, AESQC.com, to help laboratories identify, correct, and prevent analytical failure prior to releasing results. Read more...
FDA clears Automated Vasculitis Test from AESKU
AESKU Receives FDA 510(k) Clearance for Anti-Neutrophil Cytoplasmic Antibody (ANCA) test to aid in the Diagnosis of ANCA Associated Vasculitides with the HELIOS Automated immunofluorescence assay (IFA) System
(Wendelsheim, Germany / Oakland, California) AESKU.GROUP – a science-focused manufacturer of autoimmune, allergy, and infectious disease diagnostics – received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AESKUSLIDES ANCA Ethanol, and ANCA Formalin with the new HELIOS AUTOMATED IFA SYSTEM. Next to be submitted are esophageal and tissue section slides. Read more...
Thanks to all who visited us during the 2018 MEDLAB conference, and "Vielen Dank" to the conference organizers for the successful show. Read more...
nDNA (Crithidia luciliae) now FDA cleared with HELIOS System
AESKU Receives FDA 510(k) Clearance for nDNA (Crithidia luciliae) with the HELIOS AUTOMATED IFA SYSTEM.
(Wendelsheim, Germany / Oakland, California,) AESKU.GROUP received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AESKUSLIDES nDNA (Crithidia luciliae) with the new HELIOS AUTOMATED IFA SYSTEM. The kit is the second FDA cleared immunofluorescence assay on the HELIOS, after ANA HEp-2 (cleared in 2016), and will be followed by ANCA and tissue section slides. Read more...
AACC 2017 - AESKU.GROUP wraps up another successful conference
We would like to thank everyone who visited us during the 2017 AACC conference and expo last month. For those who were unable to make it to San Diego, here are a few selected highlights:
) in the interactive HELIOS picture to activate detailed information regarding the serveral HELIOS features.